Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
about
Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implicationsProgression of cutaneous melanoma: implications for treatmentPrognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up.Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancerAdjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.Management of regional lymph node basins in melanoma.Sentinel lymph node biopsy in head and neck melanoma*.Quantitative measurement of melanoma spread in sentinel lymph nodes and survivalPreoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanomaThe long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple techniqueInguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma.Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 casesUse of ultrasound to early identify, diagnose and localize metastases in melanoma patients.SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study.Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment.Surgery and radiotherapy in the treatment of cutaneous melanomaInterobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.Sentinel lymph node biopsy for melanoma: indications and rationale.Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.Clinically relevant information from sentinel lymph node biopsies of melanoma patients.Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).Interaction of tumor cells and lymphatic vessels in cancer progression.Advances in sentinel lymph node mapping for patients with melanoma.Tissue prognostic biomarkers in primary cutaneous melanoma.Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?Clinical and prognostic factors in 98 patients with malignant melanoma in China.Surgical management of melanoma: an EORTC Melanoma Group survey.Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival.Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up.Isolated tumor cells and long-term prognosis of patients with melanoma.Sentinel lymph node biopsy in malignant melanoma.Cutaneous melanoma and sentinel lymph node biopsy.
P2860
Q26996059-07D38BD9-CF2A-4391-8BA0-EB4744158000Q27001734-CF323E07-8D0F-4FB9-8AB9-ACF4EFE5BC78Q31150157-E609D422-C156-4CED-A457-FA850EBB968AQ34372934-C5E8E700-FF0F-44EC-9DFE-8FFFDAAC752DQ34409481-78A2FC58-902E-4042-876B-4470F0A29ABCQ34932726-658A647F-7C7D-4CD9-B376-88CA64DA9487Q34986199-3C29B34B-0647-4D59-A091-6B044981CF73Q34986232-D80EF2B5-2881-4215-921D-FC1D6973E6F6Q35063352-07104087-611D-4C97-A0FE-920BA9C9A9B9Q35099423-AD93F37B-E163-47A4-862E-E03967EA8721Q35856660-E3DAF005-5850-428D-8994-8A9696FDDEE6Q36155641-138F1DF9-17C9-43AD-9EB5-31123FAA01F2Q36322412-93021AD3-0837-43BB-8C40-8B920A40BCCBQ36673662-2E44D244-0051-4943-AA2A-144F829E6EBCQ36740669-220632C9-53B3-4F13-BEB7-FC2AFA43F8AFQ37025939-E2CE5E05-3938-4AED-8C6D-153DC2B10A20Q37079396-F4A89ADC-99C8-4D3E-92AA-449EBA912B3BQ37121669-2723EE3B-FCD0-454C-A156-3536676963BCQ37236435-7CBAD486-580C-4EF9-AD87-2B700F3EE054Q37266677-5A546317-7A19-46DA-8F57-E715018A8F90Q37399871-0A700C47-1B54-405F-B2DF-58D50A51E80EQ37531858-ED833BAB-EB2A-4035-9E20-815AE492D85BQ37863618-07B94407-9D09-4F9C-8411-516E8267CCB8Q37920833-9806225C-D36D-4F64-AED3-92A51A170F23Q37920834-1624352F-6DAE-44DE-84A0-549236A3E527Q37944487-49B10C81-BA5E-498A-9644-B0C4B53B8E5AQ37952237-CF703ECD-CC92-4B98-A906-57C20761AA49Q37969667-352A2A50-2C36-4CC8-ADC8-35A2FF184996Q37984125-8AE29486-BB91-45FE-938E-40F175BA6361Q38184377-2E17D67D-2FF5-4482-9A5A-51FD253E0523Q38683103-FFB87D53-015E-4597-A569-9DAFE4A4A5D9Q38740149-0F348419-248E-4486-B090-645D6E268277Q39743860-C8FA0B1B-F0FA-4E3D-85B5-8553AC761768Q40004737-B4F29402-028A-4554-B537-111588B2699FQ40305491-FBD5B768-2400-4CF2-88F1-43AD600D026FQ40922293-158A8F13-D179-4A57-B492-C496AFD09014Q42922868-AE479982-613A-4741-A0D7-5039194B4DF3Q43090910-DF72073A-F9B1-4CFC-94B6-56211D4158C2Q43167662-5880062C-7D8C-4207-96FD-8C4A68C1C01DQ43215428-F684AC3B-8373-40A4-BA82-07E56DCFA8C6
P2860
Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical relevance of melanoma ...... des to be considered negative?
@ast
Clinical relevance of melanoma ...... des to be considered negative?
@en
type
label
Clinical relevance of melanoma ...... des to be considered negative?
@ast
Clinical relevance of melanoma ...... des to be considered negative?
@en
prefLabel
Clinical relevance of melanoma ...... des to be considered negative?
@ast
Clinical relevance of melanoma ...... des to be considered negative?
@en
P2093
P356
P1433
P1476
Clinical relevance of melanoma ...... des to be considered negative?
@en
P2093
A M M Eggermont
A N van Geel
J H W de Wilt
P I M Schmitz
P304
P356
10.1093/ANNONC/MDL176
P577
2006-09-12T00:00:00Z